Globally, dizziness/vertigo is also a prevalent and challenging health issue. According to the World Health Organization (WHO), about 20% of people worldwide will experience at least one episode of
dizziness/vertigo in their lifetime (Source: WHO, 2023).
Our product specializing in neurological disease screening, has developed a wearable eye-tracking device. The solution is dedicated to improving the management and treatment efficiency of dizziness/vertigo
1. Advanced eye-tracking powered by deep learning, ensuring high anti-interference performance.
2. Quantitative data analysis supported by waveform graphs and standardized clinical metrics.
3. Certified by FDA, CE MDR, and TFDA, meeting international standards for medical devices.
4. Seamless integration into clinical workflows without the need for calibration adjustments.
Our solution delivers precise and comprehensive reports, helping clinicians confidently diagnose and manage vestibular and central nervous system disorders
The risk assessment results provided in this report help identify the need for follow-up evaluations and management strategies,enabling timely and accurate treatment. This approach not only improves quality of life but also facilitates early detection and management of potential serious health issues.
Revolutionizing Neurological and Vestibular Diagnosis with Neurobit
NeuroSwift Pro
Feat uring Reliable Eye-Tracking Technology and Automated
Diagnostics to Enhance Precision and Efficiency in Healthcare
波阿斯國際事業有限公司Boaz International Business Co, Ltd.
台灣台北市大安區忠孝東路四段320號二樓 2F, No. 320,Sec 4,Zhongxiao East Road,Taipei Ct 10643, Taiwan (R.O.C)